基于古方草乌散改良外用对踝关节骨折患者围手术期干预的临床研究

注册号:

Registration number:

ITMCTR2025001251

最近更新日期:

Date of Last Refreshed on:

2025-06-23

注册时间:

Date of Registration:

2025-06-23

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

基于古方草乌散改良外用对踝关节骨折患者围手术期干预的临床研究

Public title:

Clinical research on perioperative intervention of ankle fracture patients based on modified external application of ancient formula Caowu powder

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于古方草乌散改良外用对踝关节骨折患者围手术期干预的临床研究

Scientific title:

Clinical research on perioperative intervention of ankle fracture patients based on modified external application of ancient formula Caowu powder

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

毛廷丽

研究负责人:

毛廷丽

Applicant:

Mao Tingli

Study leader:

Mao Tingli

申请注册联系人电话:

Applicant telephone:

18223014188

研究负责人电话:

Study leader's telephone:

18223014188

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

maotinee@126.com

研究负责人电子邮件:

Study leader's E-mail:

maotinee@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区健康路1号

研究负责人通讯地址:

重庆市渝中区健康路1号

Applicant address:

No. 1 Jiankang Road Yuzhong District Chongqing City

Study leader's address:

2023(27)

申请注册联系人邮政编码:

Applicant postcode:

400010

研究负责人邮政编码:

Study leader's postcode:

400010

申请人所在单位:

重庆市急救医疗中心

Applicant's institution:

Chongqing Emergency Medical Center

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2023年伦理第27号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

重庆市第四人民医院(重庆市急救医疗中心)伦理委员会

Name of the ethic committee:

Chongqing Fourth People's Hospital(Chongqing Emergency Medical Center)Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2023/7/10 0:00:00

伦理委员会联系人:

马良慧

Contact Name of the ethic committee:

Ma Liang

伦理委员会联系地址:

重庆市渝中区健康路1号

Contact Address of the ethic committee:

No. 1 Jiankang Road Yuzhong District Chongqing City

伦理委员会联系人电话:

Contact phone of the ethic committee:

18223014188

伦理委员会联系人邮箱:

Contact email of the ethic committee:

2508374895@qq.com

研究实施负责(组长)单位:

重庆市第四人民医院(重庆市急救医疗中心)

Primary sponsor:

Chongqing Fourth People's Hospital(Chongqing Emergency Medical Center)

研究实施负责(组长)单位地址:

重庆市渝中区健康路1号

Primary sponsor's address:

No. 1 Jiankang Road Yuzhong District Chongqing City

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆市

市(区县):

渝中区

Country:

China

Province:

chongqing

City:

Yuzhong District

单位(医院):

重庆市急救医疗中心

具体地址:

重庆市渝中区健康路1号

Institution
hospital:

Chongqing Emergency Medical Center

Address:

No. 1 Jiankang Road Yuzhong District Chongqing City

经费或物资来源:

重庆市科卫联合课题

Source(s) of funding:

Chongqing Science and Health Joint Project

研究疾病:

踝关节骨折

研究疾病代码:

Target disease:

Ankle Fracture

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

1.研究并阐明消肿却痛散外用对踝关节骨折后局部软组织肿胀、疼痛的治疗效果。 2.采用肌骨超声测量,研究消肿却痛散对创伤肌肉组织的作用特点,解释中药外用对肌肉机械特性的影响。

Objectives of Study:

1. Study and elucidate the therapeutic effect of external application of Xiaozhong Quetong San on local soft tissue swelling and pain after ankle fracture. 2. Using muscle bone ultrasound measurement study the characteristics of the effect of Xiaozhong Quetong San on traumatized muscle tissue and explain the influence of external application of traditional Chinese medicine on muscle mechanical properties.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1.符合踝关节骨折诊断标准,为单侧踝关节骨折未合并其他损伤患者,经外科医师评估有手术指征。 2.患者年龄在18-70岁之间。 3.治疗前未曾进行其他相关治疗。 4.自愿参加本临床研究并签署书面知情同意书。

Inclusion criteria

1. Meets the diagnostic criteria for ankle fracture is a patient with unilateral ankle fracture without other injuries and has surgical indications evaluated by the surgeon. 2. The patient's age is between 18-70 years old. 3. No other related treatments were performed before treatment. 4. Voluntarily participate in this clinical study and sign a written informed consent form.

排除标准:

开放性骨折、皮肤破损者,或局部软组织并发症(感染、张力性水疱、坏死、筋膜室综合征)者;伴有对侧下肢损伤或肢体缺如者;多发伤患者;除踝关节骨折外存在重要血管、神经、脏器损伤等急危重症患者;合并严重心、肝、肾、血液和造血系统等严重原发疾病;精神病患者;病理性骨折;对本研究药物存在过敏反应者;有手术禁忌症或经外科医生评估不适合手术治疗者;孕期、哺乳期妇女;研究者认为不适宜参加本临床研究。

Exclusion criteria:

Patients with open fractures skin damage or local soft tissue complications (infection tension blisters necrosis compartment syndrome); Individuals with contralateral lower limb injury or limb absence; Patients with multiple injuries; In addition to ankle joint fractures there are also critically ill patients with important vascular nerve and organ injuries; Merge severe primary diseases such as heart liver kidney blood and hematopoietic system; Psychiatric patients; Pathological fracture; Individuals who have allergic reactions to the investigational drug; Patients with surgical contraindications or those assessed by surgeons as unsuitable for surgical treatment; Pregnant and lactating women; The researchers believe that it is not appropriate to participate in this clinical study.

研究实施时间:

Study execute time:

From 2023-07-10

To      2025-06-15

征募观察对象时间:

Recruiting time:

From 2023-07-10

To      2025-06-15

干预措施:

Interventions:

组别:

对照组

样本量:

38

Group:

控制组

Sample size:

干预措施:

空白对照

干预措施代码:

Intervention:

Intervention code:

组别:

治疗组

样本量:

38

Group:

Treatment group

Sample size:

干预措施:

常规治疗联合中药外敷

干预措施代码:

Intervention:

Conventional treatment combined with external application of traditional Chinese medicine

Intervention code:

样本总量 Total sample size : 76

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

重庆市

市(区县):

渝中区

Country:

Province:

City:

单位(医院):

重庆市急救医疗中心

单位级别:

重庆市急救医疗中心

Institution/hospital:

Level of the institution:

测量指标:

Outcomes:

指标中文名:

肌骨超声检查

指标类型:

次要指标

Outcome:

Muscle bone ultrasound examination

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

踝关节肿胀值

指标类型:

主要指标

Outcome:

Swelling value of ankle joint

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疼痛评分

指标类型:

次要指标

Outcome:

Visual Analog Pain Scale (VAS)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术等待时间

指标类型:

次要指标

Outcome:

Surgical waiting time

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 70
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表

Randomization Procedure (please state who generates the random number sequence and by what method):

random number table

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

http://www.medresman.org.cn/uc/index.aspx

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

http://www.medresman.org.cn/uc/index.aspx

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form CRF

数据管理委员会:

Data Managemen Committee:

No

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统